{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:31:59Z","timestamp":1781019119992,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00292-023-01192-7","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T08:02:18Z","timestamp":1682668938000},"page":"173-183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Klassifikation peripherer T-Zell-Lymphome","Classification of peripheral T-cell lymphomas"],"prefix":"10.1007","volume":"44","author":[{"given":"Falko","family":"Fend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Quintanilla-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"1192_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio\u00a0R, Amador\u00a0C, Anagnostopoulos\u00a0I et\u00a0al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720\u20131748","journal-title":"Leukemia"},{"key":"1192_CR2","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood.2019000779","volume":"134","author":"C Amador","year":"2019","unstructured":"Amador\u00a0C, Greiner\u00a0TC, Heavican\u00a0TB et al (2019) Reproducing the molecular subclassification of peripheral T\u2011cell lymphoma-NOS by immunohistochemistry. Blood 134:2159\u20132170","journal-title":"Blood"},{"key":"1192_CR3","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1182\/blood.V99.2.627","volume":"99","author":"A Attygalle","year":"2002","unstructured":"Attygalle A, Al-Jehani R, Diss TC, Munson P, Liu H, Du MQ, Isaacson PG, Dogan A (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 99:627\u2013633","journal-title":"Blood"},{"key":"1192_CR4","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1182\/blood-2018-03-785931","volume":"131","author":"CM Bollard","year":"2018","unstructured":"Bollard\u00a0CM, Cohen\u00a0JI (2018) How I treat T\u2011cell chronic active Epstein-Barr virus disease. Blood 131:2899\u20132905","journal-title":"Blood"},{"key":"1192_CR5","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo\u00a0E, Jaffe\u00a0ES, Cook\u00a0JR et\u00a0al (2022) The international consensus classification of mature lymphoid neoplasms: a\u00a0report from the clinical advisory committee. Blood 140:1229\u20131253","journal-title":"Blood"},{"key":"1192_CR6","doi-asserted-by":"publisher","first-page":"e66395","DOI":"10.7554\/eLife.66395","volume":"10","author":"S Cheng","year":"2021","unstructured":"Cheng S, Zhang W, Inghirami G et al (2021) Mutation analysis links angioimmunoblastic T\u2011cell lymphoma to clonal hematopoiesis and smoking. Elife 10:e66395. https:\/\/doi.org\/10.7554\/eLife.66395","journal-title":"Elife"},{"key":"1192_CR7","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","volume":"34","author":"S Chiba","year":"2020","unstructured":"Chiba\u00a0S, Sakata-Yanagimoto\u00a0M (2020) Advances in understanding of angioimmunoblastic T\u2011cell lymphoma. Leukemia 34:2592\u20132606","journal-title":"Leukemia"},{"key":"1192_CR8","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood.2022015854","volume":"140","author":"L De Leval","year":"2022","unstructured":"De Leval\u00a0L, Alizadeh\u00a0AA, Bergsagel\u00a0PL et\u00a0al (2022) Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 140:2193\u20132227","journal-title":"Blood"},{"key":"1192_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00428-022-03434-0","volume":"482","author":"L De Leval","year":"2023","unstructured":"De Leval\u00a0L, Feldman\u00a0AL, Pileri\u00a0S et al (2023) Extranodal T\u2011 and NK-cell lymphomas. Virchows Arch 482:245\u2013264","journal-title":"Virchows Arch"},{"key":"1192_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ajcp\/aqac105","volume":"159","author":"SD Dojcinov","year":"2023","unstructured":"Dojcinov\u00a0SD, Quintanilla-Martinez\u00a0L (2023) How I diagnose EBV-positive B\u2011 and T\u2011cell lymphoproliferative disorders. Am J Clin Pathol 159:14\u201333","journal-title":"Am J Clin Pathol"},{"key":"1192_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00428-022-03412-6","volume":"482","author":"AL Feldman","year":"2023","unstructured":"Feldman\u00a0AL, Laurent\u00a0C, Narbaitz\u00a0M et al (2023) Classification and diagnostic evaluation of nodal T\u2011 and NK-cell lymphomas. Virchows Arch 482:265\u2013279","journal-title":"Virchows Arch"},{"key":"1192_CR12","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1097\/PAS.0000000000001941","volume":"46","author":"AL Feldman","year":"2022","unstructured":"Feldman\u00a0AL, Oishi\u00a0N, Ketterling\u00a0RP et\u00a0al (2022) Immunohistochemical approach to genetic subtyping of anaplastic large cell lymphoma. Am J Surg Pathol 46:1490\u20131499","journal-title":"Am J Surg Pathol"},{"key":"1192_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00428-022-03421-5","volume":"482","author":"JR Goodlad","year":"2023","unstructured":"Goodlad\u00a0JR, Cerroni\u00a0L, Swerdlow\u00a0SH (2023) Recent advances in cutaneous lymphoma-implications for current and future classifications. Virchows Arch 482:281\u2013298","journal-title":"Virchows Arch"},{"key":"1192_CR14","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","volume":"133","author":"TB Heavican","year":"2019","unstructured":"Heavican\u00a0TB, Bouska\u00a0A, Yu\u00a0J et al (2019) Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T\u2011cell lymphoma. Blood 133:1664\u20131676","journal-title":"Blood"},{"key":"1192_CR15","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","volume":"123","author":"J Iqbal","year":"2014","unstructured":"Iqbal\u00a0J, Wright\u00a0G, Wang\u00a0C et al (2014) Gene expression signatures delineate biological and prognostic subgroups in peripheral T\u2011cell lymphoma. Blood 123:2915\u20132923","journal-title":"Blood"},{"key":"1192_CR16","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/bjd.20973","volume":"186","author":"W Kempf","year":"2022","unstructured":"Kempf\u00a0W, Petrella\u00a0T, Willemze\u00a0R et al (2022) Clinical, histopathological and prognostic features of primary cutaneous acral CD8(+) T\u2011cell lymphoma and other dermal CD8(+) cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop. Br J Dermatol 186:887\u2013897","journal-title":"Br J Dermatol"},{"key":"1192_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/annonc\/mdv575","volume":"27","author":"C Laurent","year":"2016","unstructured":"Laurent\u00a0C, Delas\u00a0A, Gaulard\u00a0P et al (2016) Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol 27:306\u2013314","journal-title":"Ann Oncol"},{"key":"1192_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1053\/j.semdp.2019.12.002","volume":"37","author":"V Leventaki","year":"2020","unstructured":"Leventaki\u00a0V, Bhattacharyya\u00a0S, Lim\u00a0MS (2020) Pathology and genetics of anaplastic large cell lymphoma. Semin Diagn Pathol 37:57\u201371","journal-title":"Semin Diagn Pathol"},{"key":"1192_CR19","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1182\/bloodadvances.2020001636","volume":"4","author":"NE Lewis","year":"2020","unstructured":"Lewis\u00a0NE, Petrova-Drus\u00a0K, Huet\u00a0S et al (2020) Clonal hematopoiesis in angioimmunoblastic T\u2011cell lymphoma with divergent evolution to myeloid neoplasms. Blood Adv 4:2261\u20132271","journal-title":"Blood Adv"},{"key":"1192_CR20","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1182\/blood-2010-08-302737","volume":"117","author":"A Mansoor","year":"2011","unstructured":"Mansoor\u00a0A, Pittaluga\u00a0S, Beck\u00a0PL et al (2011) NK-cell enteropathy: a\u00a0benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a\u00a0unique case series. Blood 117:1447\u20131452","journal-title":"Blood"},{"key":"1192_CR21","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1084\/jem.20160894","volume":"214","author":"AB Moffitt","year":"2017","unstructured":"Moffitt\u00a0AB, Ondrejka\u00a0SL, Mckinney\u00a0M et al (2017) Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. J\u00a0Exp Med 214:1371\u20131386","journal-title":"J Exp Med"},{"key":"1192_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00428-019-02704-8","volume":"476","author":"S Montes-Moreno","year":"2020","unstructured":"Montes-Moreno\u00a0S, King\u00a0RL, Oschlies\u00a0I et al (2020) Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas. Virchows Arch 476:667\u2013681","journal-title":"Virchows Arch"},{"key":"1192_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3324\/haematol.2017.180430","volume":"103","author":"SB Ng","year":"2018","unstructured":"Ng\u00a0SB, Chung\u00a0TH, Kato\u00a0S et al (2018) Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a\u00a0distinct molecular signature and copy number changes. Haematologica 103:278\u2013287","journal-title":"Haematologica"},{"key":"1192_CR24","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1309\/A8FHDA0VVRJ05GJP","volume":"127","author":"DP O\u2019malley","year":"2007","unstructured":"O\u2019malley\u00a0DP (2007) T\u2011cell large granular leukemia and related proliferations. Am J Clin Pathol 127:850\u2013859","journal-title":"Am J Clin Pathol"},{"key":"1192_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/his.14834","volume":"82","author":"I Oschlies","year":"2023","unstructured":"Oschlies\u00a0I, Kock\u00a0K, Wuseke\u00a0T et al (2023) Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4(+) small or medium T\u2011cell lymphoproliferative disorder. Histopathology 82:485\u2013494","journal-title":"Histopathology"},{"key":"1192_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00292-022-01081-5","volume":"43","author":"M Overkamp","year":"2022","unstructured":"Overkamp\u00a0M, Quintanilla-Martinez\u00a0L, Fend\u00a0F (2022) EBV-associated lymphoproliferative disorders. Pathologie 43:282\u2013291","journal-title":"Pathologie"},{"key":"1192_CR27","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","volume":"124","author":"ER Parrilla Castellar","year":"2014","unstructured":"Parrilla Castellar\u00a0ER, Jaffe\u00a0ES, Said\u00a0JW et al (2014) ALK-negative anaplastic large cell lymphoma is a\u00a0genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124:1473\u20131480","journal-title":"Blood"},{"key":"1192_CR28","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1182\/blood.2019004118","volume":"136","author":"B Pro","year":"2020","unstructured":"Pro\u00a0B, Allen\u00a0P, Behdad\u00a0A (2020) Hepatosplenic T\u2011cell lymphoma: a\u00a0rare but challenging entity. Blood 136:2018\u20132026","journal-title":"Blood"},{"key":"1192_CR29","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281222","author":"L Qiu","year":"2022","unstructured":"Qiu\u00a0L, Tang\u00a0G, Li\u00a0S et al (2022) DUSP22 rearrangement is associated with distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2022.281222","journal-title":"Haematologica"},{"key":"1192_CR30","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","volume":"482","author":"L Quintanilla-Martinez","year":"2023","unstructured":"Quintanilla-Martinez\u00a0L, Swerdlow\u00a0SH, Tousseyn\u00a0T et al (2023) New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders. Virchows Arch 482:227\u2013244","journal-title":"Virchows Arch"},{"key":"1192_CR31","doi-asserted-by":"publisher","first-page":"12602","DOI":"10.1038\/ncomms12602","volume":"7","author":"A Roberti","year":"2016","unstructured":"Roberti\u00a0A, Dobay\u00a0MP, Bisig\u00a0B et al (2016) Type II enteropathy-associated T\u2011cell lymphoma features a\u00a0unique genomic profile with highly recurrent SETD2 alterations. Nat Commun 7:12602","journal-title":"Nat Commun"},{"key":"1192_CR32","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1182\/blood-2018-01-830968","volume":"131","author":"A Sharma","year":"2018","unstructured":"Sharma\u00a0A, Oishi\u00a0N, Boddicker\u00a0RL et al (2018) Recurrent STAT3-JAK2 fusions in indolent T\u2011cell lymphoproliferative disorder of the gastrointestinal tract. Blood 131:2262\u20132266","journal-title":"Blood"},{"key":"1192_CR33","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281442","author":"D Sibon","year":"2022","unstructured":"Sibon\u00a0D, Bisig\u00a0B, Bonnet\u00a0C et al (2022) ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a\u00a0LYSA study. Haematologica. https:\/\/doi.org\/10.3324\/haematol.2022.281442","journal-title":"Haematologica"},{"key":"1192_CR34","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/PAS.0000000000001658","volume":"45","author":"CR Soderquist","year":"2021","unstructured":"Soderquist\u00a0CR, Lewis\u00a0SK, Gru\u00a0AA et\u00a0al (2021) Immunophenotypic spectrum and genomic landscape of refractory celiac disease type II. Am J Surg Pathol 45:905\u2013916","journal-title":"Am J Surg Pathol"},{"key":"1192_CR35","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41379-019-0254-4","volume":"32","author":"J Steinhilber","year":"2019","unstructured":"Steinhilber\u00a0J, Mederake\u00a0M, Bonzheim\u00a0I et al (2019) The pathological features of angioimmunoblastic T\u2011cell lymphomas with IDH2(R172) mutations. Mod Pathol 32:1123\u20131134","journal-title":"Mod Pathol"},{"key":"1192_CR36","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2017","unstructured":"Swerdlow\u00a0S, Campo\u00a0E, Harris\u00a0N et\u00a0al (Hrsg) (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon"},{"key":"1192_CR37","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.1182\/blood-2010-06-290650","volume":"116","author":"K Takeuchi","year":"2010","unstructured":"Takeuchi\u00a0K, Yokoyama\u00a0M, Ishizawa\u00a0S et al (2010) Lymphomatoid gastropathy: a\u00a0distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood 116:5631\u20135637","journal-title":"Blood"},{"key":"1192_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41379-021-00937-0","volume":"35","author":"F Vega","year":"2022","unstructured":"Vega\u00a0F, Amador\u00a0C, Chadburn\u00a0A et al (2022) Genetic profiling and biomarkers in peripheral T\u2011cell lymphomas: current role in the diagnostic work-up. Mod Pathol 35:306\u2013318","journal-title":"Mod Pathol"},{"key":"1192_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3324\/haematol.2022.281226","volume":"108","author":"L Veloza","year":"2023","unstructured":"Veloza\u00a0L, Cavalieri\u00a0D, Missiaglia\u00a0E et al (2023) Monomorphic epitheliotropic intestinal T\u2011cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome. Haematologica 108:181\u2013195","journal-title":"Haematologica"},{"key":"1192_CR40","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","volume":"133","author":"R Willemze","year":"2019","unstructured":"Willemze\u00a0R, Cerroni\u00a0L, Kempf\u00a0W et al (2019) The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 133:1703\u20131714","journal-title":"Blood"},{"key":"1192_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ajcp\/aqab090","volume":"156","author":"Y Xie","year":"2021","unstructured":"Xie\u00a0Y, Jaffe\u00a0ES (2021) How I diagnose angioimmunoblastic T\u2011cell lymphoma. Am J Clin Pathol 156:1\u201314","journal-title":"Am J Clin Pathol"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01192-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-023-01192-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01192-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T17:23:11Z","timestamp":1702315391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-023-01192-7"}},"subtitle":["Neuigkeiten und offene Fragen","News and open questions"],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1192"],"URL":"https:\/\/doi.org\/10.1007\/s00292-023-01192-7","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"value":"2731-7188","type":"print"},{"value":"2731-7196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"7 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Fend, L.\u00a0Quintanilla-Martinez und W.\u00a0Klapper geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}